Kyle D. Kuvalanka
2015
In 2015, Kyle D. Kuvalanka earned a total compensation of $1.5M as Chief Operating Officer at Syros Pharmaceuticals.
Compensation breakdown
| Bonus | $122,500 |
|---|---|
| Option Awards | $1,262,638 |
| Salary | $106,692 |
| Other | $68 |
| Total | $1,491,898 |
Kuvalanka received $1.3M in option awards, accounting for 85% of the total pay in 2015.
Kuvalanka also received $122.5K in bonus, $106.7K in salary and $68 in other compensation.
Rankings
In 2015, Kyle D. Kuvalanka's compensation ranked 6,024th out of 13,638 executives tracked by ExecPay. In other words, Kuvalanka earned more than 55.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,024 out of 13,638 | 56th |
Division Manufacturing | 2,254 out of 5,190 | 57th |
Major group Chemicals And Allied Products | 814 out of 1,854 | 56th |
Industry group Drugs | 650 out of 1,528 | 58th |
Industry Pharmaceutical Preparations | 506 out of 1,182 | 57th |
Source: SEC filing on April 25, 2017.
Kuvalanka's colleagues
We found two more compensation records of executives who worked with Kyle D. Kuvalanka at Syros Pharmaceuticals in 2015.